Michael Klichinsky

Plus aucun poste en cours

Fortune : - $ au 31/05/2026

36 ans

Consumer Services

Health Technology

Profil

Michael Klichinsky is the founder of Carisma Therapeutics, Inc., founded in 2016, where the title held was Chief Scientific Officer from 2022 to 2025.
Dr. Klichinsky was the founder of CTx Operations, Inc., founded in 2022, where the title held was Chief Scientific Officer from 2022 to 2025.
Dr. Klichinsky earned doctorates from the University of Pennsylvania and the University of the Sciences in Philadelphia.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CARISMA THERAPEUTICS, INC. -.--%	07/10/2025	0 ( -.--% )	- $	31/05/2026

Anciens postes connus de Michael Klichinsky

Sociétés	Poste	Fin
CARISMA THERAPEUTICS, INC.	Fondateur	15/10/2025
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer	Fondateur	01/10/2025

Voir l'expérience en détail de Michael Klichinsky

Formation de Michael Klichinsky

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Michael Klichinsky

Sociétés liées

Entreprise privées	4
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of the Sciences in Philadelphia University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CTx Operations, Inc. CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer	Health Technology
Carisma Therapeutics, Inc. Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer	Health Technology